Clinical Trial

Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated September 5, 2025 (before its estimated September 10, 2025 completion). Its status may not reflect the trial's current state.
Summary
Along with the current clinical trial, the impact of adding atorvastatin or rosuvastatin in the first 24 hours on the clinical outcomes of first-ever large-vessel ischemic stroke patients treated with clopidogrel assessed through NIHSS, mRS, and possible adverse effects.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-04-06.
Trial Details
NCT Number NCT06360120
Lead Sponsor Kafrelsheikh University
Conditions Ischemic Stroke
Enrollment 600 participants
Start Date 2024-04-10
Primary Completion 2025-09-10 (estimated)
Study Completion 2025-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-05